close 74% jaeinvestorite kontodest jääb antud teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse. Investeerimisega kaasnevad riskid ja need ei ole sobilikud kõigile investoritele. Hinnavahelepingud on keerukad instrumendid, millega kaasneb võimenduse tõttu suur risk kaotada raha kiiresti. 74% jaeinvestorite kontodest jääb antud teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse. Palume teil kaaluda, kas hinnavahelepingute süsteem on teile arusaadav ja kas olete valmis võtma riski, mis suure tõenäoususega on kahjumlik.
Change languageEesti
Ülevaade

LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

Kodu・Aktsiate loetelu・Clearside Biomedical Inc
Search

Clearside Biomedical Inc

Suletud

0

Neutraalne

Hinna uuendus 1. jaan 1970, 00:00 UTC

OstaMüü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

Max

Põhinäitajad

By Trading Economics

Sissetulek

-1.5M

-6M

Müük

-291K

201K

Aktsiakasum

-1.14

Kasumimarginaal

-2,971.144

Töötajad

32

EBITDA

-1.7M

-3.3M

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

26. märts 2026

Turustatistika

By TradingEconomics

Turukapital

-17M

2.1M

Eelmine avamishind

0

Eelmine sulgemishind

0

Tehniline skoor

By Trading Central

Kindlus

Neutral Evidence

0.8417 / 0.8939 Toetus ja vastupanu

Clearside Biomedical Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

24. veebr 2026, 23:07 UTC

Tulu

Woolworths 1st Half Profit Hit By Worker Pay Dispute, Still Boosts Dividend

DJ

Loe

24. veebr 2026, 23:01 UTC

Tulu

Fortescue 1st Half Net Profit, Dividend Rise on Higher Shipments, Prices -- Update

DJ

Loe

24. veebr 2026, 22:59 UTC

Tulu

WiseTech to Cut 2,000 Jobs as It Asks AI to Boost Profitability -- Update

DJ

Loe

24. veebr 2026, 22:42 UTC

Tulu

WiseTech to Cut 2,000 Jobs as It Asks AI to Boost Profitability

DJ

Loe

24. veebr 2026, 22:24 UTC

Omandamised, ülevõtmised, äriostud

Warner Bros. Discovery Board Says Paramount Skydance's New Proposal Could Top Netflix Agreement -- Update

DJ

Loe

24. veebr 2026, 23:46 UTC

Market Talk

Gold Edges Higher Amid Possible Position Adjustments -- Market Talk

DJ

Loe

24. veebr 2026, 23:36 UTC

Market Talk

Nikkei May Rise, Tracking Wall Street's Rebound -- Market Talk

DJ

Loe

24. veebr 2026, 23:30 UTC

Market Talk

Fortescue's Copper Bet Is Long Term, While Iron Ore Remains Near-Term Driver -- Market Talk

DJ

Loe

24. veebr 2026, 23:20 UTC

Market Talk

Fortescue Dividend Beat Overshadows Profit Miss -- Market Talk

DJ

Loe

24. veebr 2026, 23:20 UTC

Market Talk

Global Equities Roundup: Market Talk

DJ

Loe

24. veebr 2026, 23:16 UTC

Tulu

Oversea-Chinese Banking Corp.'s CEO: "Looking Ahead, We Remain Cautious Yet Positive">O39.SG

DJ

Loe

24. veebr 2026, 23:13 UTC

Tulu

Oversea-Chinese Banking Corp. FY25 Non-Interest Income S$5.46B Vs. S$4.72B >O39.SG

DJ

Loe

24. veebr 2026, 23:12 UTC

Tulu

Oversea-Chinese Banking Corp.: FY25 Net Interest Income S$9.15B Vs. S$9.76B>O39.SG

DJ

Loe

24. veebr 2026, 23:10 UTC

Tulu

Oversea-Chinese Banking Corp. FY25 NPL Ratio 0.9%, Unchanged on Year>O39.SG

DJ

Loe

24. veebr 2026, 23:10 UTC

Tulu

Oversea-Chinese Banking Corp. FY25 Net Interest Margin 1.91%, Down 29bps on Year>O39.SG

DJ

Loe

24. veebr 2026, 23:08 UTC

Tulu

Oversea-Chinese Banking Corp. FY25 Net S$7.42B Vs. Net S$7.59B >O39.SG

DJ

Loe

24. veebr 2026, 23:07 UTC

Tulu

Oversea-Chinese Banking Corp. FY25 Total Income S$14.61B Vs. S$14.47B>O39.SG

DJ

Loe

24. veebr 2026, 22:52 UTC

Tulu

Woolworths 1H Profit Hit By Worker Pay Dispute, Still Boosts Dividend

DJ

Loe

24. veebr 2026, 22:46 UTC

Tulu

Fortescue 1H Net Profit, Dividend Rise on Higher Shipments, Prices -- Update

DJ

Loe

24. veebr 2026, 22:31 UTC

Omandamised, ülevõtmised, äriostud

Warner Receives New Bid From Paramount -- 3rd Update

DJ

Loe

24. veebr 2026, 22:29 UTC

Tulu

Woolworths: FY Ebit Growth for Australian Food Expected at Upper End of Mid-to-High Single Digit Range Provided in August

DJ

Loe

24. veebr 2026, 22:28 UTC

Tulu

Woolworths: Australian Food Current Growth Rates Reflect Some Benefit from Cycling of Industrial Action Impacts

DJ

Loe

24. veebr 2026, 22:27 UTC

Tulu

Woolworths: Australian Food Sales +7.2% Excluding Tobacco in 2H First Seven Weeks

DJ

Loe

24. veebr 2026, 22:27 UTC

Tulu

Woolworths: Australian Food Sales +5.8% in 2H First Seven Weeks

DJ

Loe

24. veebr 2026, 22:25 UTC

Tulu

Woolworths: Customers Continue to be Value-Focused, Shopping Multiple Retailers in Highly Competitive Environment

DJ

Loe

24. veebr 2026, 22:24 UTC

Tulu

Woolworths: Trading in 3Q to Date Has Been Strong in Australian Food

DJ

Loe

24. veebr 2026, 22:23 UTC

Tulu

Woolworths 1H Group Sales A$37.1 Bln, Up 3.4%

DJ

Loe

24. veebr 2026, 22:22 UTC

Tulu

Woolworths Interim Dividend 45 Australian Cents/Share

DJ

Loe

24. veebr 2026, 22:22 UTC

Tulu

Woolworths 1H Profit Before Significant Items A$859 Mln, Up 16.4%

DJ

Loe

24. veebr 2026, 22:21 UTC

Tulu

Woolworths 1H Statutory Net Profit A$374 Mln, Down 49.4%

DJ

Loe

Võrdlus sarnastega

Hinnamuutus

Clearside Biomedical Inc Prognoos

Hinnangu Konsensus

By TipRanks

Neutraalne

1 ratings

0

Osta

1

Hoia

0

Müü

Põhineb 1 analüütiku instrumendi Clearside Biomedical Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

0.8417 / 0.8939Toetus ja vastupanu

Lühikene perspektiiv

Neutral Evidence

The bullish and bearish events are balanced.

Keskpikk perspektiiv

Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Pikk perspektiiv

Weak Bearish Evidence

There is one bearish event.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Muud aktsiad sektorist

LLY

Eli Lilly and Co.

1,042.27

↓-1.11%

JNJ

Johnson and Johnson

246.2

↑ +0.25%

ABBV

AbbVie Inc

228.42

↓-0.4%

NVS

Novartis AG

166.68

↑ +1.33%

MRK

Merck & Co Inc.

123.89

↑ +0.15%
help-icon Live chat